Drug Trial Radar · NCT05693558
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
Last checked: Nov 19, 2026Latest source record: Jan 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4
Planned (sponsor's estimate)
Start
Nov 24, 2022
Primary completion
Jan 2025
Study completion Jan 2026
Sponsor
- Lead sponsor
- Novadip BiosciencesIndustry
- Sponsor type
- Industry
- First posted
- Jan 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 8 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A single arm, multi-country, multi-center study in pediatric patients, suffering from congenital pseudarthrosis of the tibia (CPT), treated during the primary surgical intervention with NVD-003, an autologous 3D scaffold free osteogenic graft.
Conditions
- Congenital Pseudarthrosis of Tibia
Interventions
NVD-003, an autologous 3D scaffold free osteogenic graftBiological
Bone correction and grafting surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary objective: safety short (≤3 months) and mid long-term (>3-12 months): : Descriptive analysisTime frame: Up to 12 months post-grafting surgery
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Adult/Pediatric Limb Lengthening and Reconstruction - International Center for Limb Lengthening - Rubin Institute for Advanced Orthopedics Baltimore
Baltimore, Maryland
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.